Brain imaging and neuroimaging Market to be driven by substantial growth Rising prevalence of neurological disorders is expected to drive market expansion in the near future

Brain Imaging Neuroimaging Market Highlights

The global brain imaging and neuroimaging market is accounted to register a CAGR of 5.80% during the forecast period and is estimated to reach USD 21.9 Billion by 2032.

The brain imaging and neuroimaging market are witnessing substantial growth due to advancements in medical imaging technologies. These innovations enable more accurate diagnosis and monitoring of neurological disorders such as Alzheimer's, Parkinson's, and stroke. With increasing research and a growing aging population, the market is poised for continued expansion, contributing to improved patient care and outcomes.

Key Players

MRFR recognizes the following companies as the key players in the global Brain imaging and neuroimaging market— GE, Siemens, Canon, Hitachi Medical Systems, Medtronic PLC.,EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co. Ltd., Elekta, Varian medical Systems, General Electric Company, Philips Healthcare, Toshiba Medical Systems, Sanrad medical Systems Pvt. Ltd, and Esaote SpA.

Segment Analysis

The global brain imaging and neuroimaging market has been segmented based imaging type and end user.

On the basis of imaging type, the market is segmented into functional magnetic resonance imaging (FMRI), compound tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG) and near infrared spectroscopy (NIRS)]. The functional magnetic resonance imaging (FMRI) segment dominated the market in 2022 due to the rising use of FMRI in the diagnosis and treatment of neurological conditions such as epilepsy, Parkinson's disease, and Alzheimer's disease.  

Based on end user, the global brain imaging and neuroimaging market has been segmented into hospitals, ambulatory surgical centers and clinics and diagnostic centers. The hospitals category generated the most income in 2022. These developments have made it possible to see the structure and functioning of the brain precisely, which helps with neurological problem diagnosis and therapy. Academic institutions and hospitals frequently collaborate on research projects.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Brain Imaging Neuroimaging Market Research Report

Regional Analysis

The global brain imaging and neuroimaging market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Brain imaging and neuroimaging market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Brain imaging and neuroimaging market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Brain imaging and neuroimaging market comprises of Middle East, Africa, and Latin America.

The North America brain imaging and neuroimaging market dominated this market in 2022 (45.80%). Internationally renowned hubs for innovative neuroscience research and practice are located in North America. In Boston, Massachusetts, prestigious universities like Harvard University and MIT collaborate on cutting-edge brain imaging research. This collaboration advances technology and leads to the development of cutting-edge neuroimaging techniques.

Moreover, the market for neuroimaging and brain imaging has the second-largest share in Europe. Multidisciplinary neuroscience research is highly valued by European institutions, which promote collaborations between computer scientists, radiologists, neurologists, and psychologists. The Oxford Centre for Functional MRI of the Brain (FMRIB) in the United Kingdom is renowned for its multidisciplinary approach to neuroimaging.

Additionally, the Asia-Pacific brain imaging and neuroimaging market is expected to grow at the fastest CAGR from 2023 to 2032. As the region's population ages quickly and the number of non-communicable diseases rises, there is a growing demand for neurological healthcare services. Japan's aging population and the use of neuroimaging in geriatric care at organizations like the National Center for Geriatrics and Gerontology serve as excellent examples of this trend.

Furthermore, the rest of the world's brain imaging and neuroimaging market is divided into the Middle East, Africa, and Latin America. The Latin America brain imaging and neuroimaging market is advancing rapidly with innovative diagnostic technologies. These tools play a crucial role in diagnosing and monitoring neurological disorders, such as Alzheimer's and stroke. As healthcare infrastructure improves and awareness grows, the market is expanding to meet the region's increasing demands for accurate and early detection, contributing to enhanced patient care and management.

Key Findings of the Study

• The global brain imaging and neuroimaging market is expected to reach USD 21.9 Billion by 2032, at a CAGR of 5.80% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to an increasing need for neurological healthcare services as the region experiences demographic changes.


• Based on end user, the hospitals segment was attributed to holding the largest market in 2022.


• GE, Siemens, Canon, Hitachi Medical Systems, Medtronic PLC.,EB Neuro S.p.A., Neurosoft, MinFound Medical Systems Co. Ltd., Elekta, Varian medical Systems, General Electric Company, Philips Healthcare, Toshiba Medical Systems, Sanrad medical Systems Pvt. Ltd, and Esaote SpA.